Catalogue peptide and compound research
Explore in-depth research on the other peptides, blends and related compounds in the catalogue. Each guide has its own study sources, terminology, results and limitations.
By Manchester Peptides ·
Find a research guide by subject
Start with the exact compound or blend. A human trial, an animal experiment and a laboratory measurement answer different questions. Each guide explains the research design alongside the findings so you can trace a claim to the original source.
Connective tissue, skin and peptide blends
Read the original tendon-cell, wound, collagen and intestinal inflammation studies. The blend guides explain why combining ingredients raises its own evidence questions.
Detailed evidence guide
Wolverine blend research: BPC-157 plus TB-500
Compare the individual tendon-cell and thymosin beta-4 studies with the evidence needed to test the combined Wolverine blend.
Read the study breakdown →Detailed evidence guideBPC-157 tendon research and human evidence
Read the tendon-cell experiment, the newer human evidence review and the difference between cell migration and recovery after injury.
Read the study breakdown →Detailed evidence guideTB-500 vs thymosin beta-4: sequence and wound research
See why full-length thymosin beta-4 and the fragment associated with TB-500 must be identified separately when reading research.
Read the study breakdown →Detailed evidence guideKLOW peptide blend ingredients and evidence
Read what GHK-Cu, BPC-157, TB-500 and KPV studies can establish about each ingredient and what remains unknown about their combination.
Read the study breakdown →Detailed evidence guideGHK-Cu copper peptide research for skin and collagen
Separate fibroblast collagen experiments from evidence for topical cosmetic formulations and from claims about other routes.
Read the study breakdown →Detailed evidence guideKPV peptide research, PepT1 and intestinal inflammation
Understand what KPV did in intestinal cells and mouse colitis models and why those results do not establish human treatment outcomes.
Read the study breakdown →Cellular metabolism and ageing research
Follow the published work on mitochondrial signalling, cellular ageing and NAD+ metabolism. The guides distinguish molecules measured in cells or blood from outcomes experienced by people.
Detailed evidence guide
MOTS-C mitochondrial peptide, exercise and metabolism research
Compare the original metabolic experiments with exercise-related measurements and learn why a measured biomarker differs from treatment evidence.
Read the study breakdown →Detailed evidence guideEpitalon telomere and telomerase research
Read what Epitalon studies measured in cultured human cells and why they cannot establish lifespan or anti-ageing benefits in people.
Read the study breakdown →Detailed evidence guideNAD+ infusion research, metabolism and NAD precursors
Distinguish NAD+ from NADH, NR and NMN and see what the human infusion pilot measured in blood and urine.
Read the study breakdown →Neuroscience and pigmentation research
Explore experimental Semax work, the human Selank literature and early Melanotan II research alongside NHS tanning safety information.
Detailed evidence guide
Semax peptide research: experimental stroke and cognition claims
Read how Semax studies investigate brain injury and gene expression and why those findings do not establish a cognitive benefit in healthy people.
Read the study breakdown →Detailed evidence guideSelank peptide research on anxiety, symptoms and evidence quality
Read what a small clinical study assessed and why its population, comparison group and outcome measures matter for claims about anxiety.
Read the study breakdown →Detailed evidence guideMelanotan II (MT2): pigmentation research and safety
Read what the first Melanotan II study observed, how small it was and what NHS guidance says about tanning injections and nasal sprays.
Read the study breakdown →Growth, fertility and insulin reference
Compare growth-factor analogues, reproductive hormone preparations and two different insulin action profiles. The medicine references identify the authorised product and the clinical question.
Detailed evidence guide
IGF-1 LR3 research: binding proteins, growth and animal studies
Compare Long R3 IGF-1 with native IGF-1 and mecasermin, and read why animal growth responses do not establish human muscle outcomes.
Read the study breakdown →Detailed evidence guideHGH and somatropin research: growth hormone replacement evidence
Learn how clinical evidence for prescribed somatropin differs from claims about HGH, ageing and performance.
Read the study breakdown →Detailed evidence guidehCG research: chorionic gonadotrophin, fertility and LH signalling
Understand the difference between hCG preparations, their role in monitored fertility care and why the outcome depends on the exact product.
Read the study breakdown →Detailed evidence guidehMG menotrophin research: FSH and LH activity in fertility care
Understand what hMG means, how it differs from hCG and how clinical evidence describes monitored fertility outcomes.
Read the study breakdown →Detailed evidence guideNovoRapid and insulin aspart: rapid-acting insulin evidence
A UK medicine reference explaining rapid-acting insulin, clinical endpoints, hypoglycaemia and differences from basal insulin.
Read the study breakdown →Detailed evidence guideLantus and insulin glargine: long-acting basal insulin evidence
A UK medicine reference explaining basal insulin, how glargine studies measure outcomes and why insulin formulations differ.
Read the study breakdown →Weight-loss clinical research
Read the dedicated reports together: Mounjaro, Retatrutide and Eloralintide. The side-by-side comparison explains which studies directly compared interventions.